Abstract
MEKs, which operate within the ERK cascade, shuttle into the nucleus, but are rapidly exported from this location, forming an apparent cytosolic distribution both before and after stimulation. Two different mechanisms have been proposed for the nuclear translocation of MEKs. One of them involves a constant and non-regulated shuttling of MEKs into the nucleus operating both before and after mitogenic stimulation. The other mechanism seems to require the activity of MEKs and is facilitated in response to mitogenic stimulation. Here we show that these two mechanisms may coexist in the same cells. We found that leptomycin B (LMB), a potent inhibitor of nuclear export, induces a nuclear accumulation of MEKs, and this was significantly facilitated by stimulation of LMB-treated cells with EGF, TPA and peroxovanadate. The EGF-stimulated, but not the LMB-induced translocation was attenuated by MEK inhibitors and by using inactive forms of MEK1. We also show that LMB slightly activates the ERK cascade, but this activity only partially induces the nuclear accumulation of MEKs in cells treated by LMB alone. Thus, MEKs translocate into the nucleus by a combination of non-regulated and stimulated processes that contribute to the nuclear translocation of MEKs either in resting cells or upon mitogenic stimulation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- DP-ERK Ab:
-
anti diphospho-ERK antibody
- ERK:
-
extracellular signal-regulated kinase
- GFP:
-
green fluorescence protein
- LMB:
-
leptomycin B
- MAPK:
-
mitogen-activated protein kinase
- MBP:
-
myelin basic protein
- MEK:
-
MAPK/ERK kinase
- TPA:
-
tetradecanoyl phorbol acetate
References
Adachi M, Fukuda M, Nishida E . 1999 EMBO J. 18: 5347–5358
Adachi M, Fukuda M, Nishida E . 2000 J. Cell Biol. 148: 849–856
Akey CW . 1991 Semin. Cell. Biol. 2: 167–177
Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, Behr JP . 1995 Proc. Natl. Acad. Sci. USA 92: 7297–7301
Chang L, Karin M . 2001 Nature 410: 37–40
Chen RH, Sarnecki C, Blenis J . 1992 Mol. Cell. Biol. 12: 915–927
Fukuda M, Asano S, Nakamura T, Adachi M, Yoshida M, Yanagida M, Nishida E . 1997a Nature 390: 308–311
Fukuda M, Gotoh I, Adachi M, Gotoh Y, Nishida E . 1997b J. Biol. Chem. 272: 32642–32648
Fukuda M, Gotoh Y, Nishida E . 1997c EMBO J. 16: 1901–1908
Fukuda M, Gotoh I, Gotoh Y, Nishida E . 1996 J. Biol. Chem. 271: 20024–20028
Gotoh I, Fukuda M, Adachi M, Nishida E . 1999 J. Biol. Chem. 274: 11874–11880
Harootunian AT, Adams SR, Wen W, Meinkoth JL, Taylor SS, Tsien RY . 1993 Mol. Cell. Biol. 4: 993–1002
Jaaro H, Rubinfeld H, Hanoch T, Seger R . 1997 Proc. Natl. Acad. Sci. USA 94: 3742–3747
Lenormand P, Sardet C, Pages G, L'Allemain G, Brunet A, Pouyssegur J . 1993 J. Cell Biol. 122: 1079–1088
Lewis TS, Shapiro PS, Ahn NG . 1998 Adv. Cancer Res. 74: 49–139
Pearson G, Robinson F, Beers Gibson T, Xu B, Karandikar M, Berman K, Cobb MH . 2001 Endocr. Rev. 22: 153–183
Reszka AA, Seger R, Diltz CD, Krebs EG, Fischer EH . 1995 Proc. Natl. Acad. Sci. USA 92: 8881–8885
Rubinfeld H, Hanoch T, Seger R . 1999 J. Biol. Chem. 274: 30349–30352
Seger R, Krebs EG . 1995 FASEB J. 9: 726–735
Seger R, Ahn NG, Posada J, Munar ES, Jensen AM, Cooper JA, Cobb MH, Krebs EG . 1992a J. Biol. Chem. 267: 14373–14381
Seger R, Seger D, Lozeman FJ, Ahn NG, Graves LM, Campbell JS, Ericsson L, Harrylock M, Jensen AM, Krebs EG . 1992b J. Biol. Chem., 267: 25628–25631
Seger R, Seger D, Reszka AA, Munar ES, Eldar-Finkelman H, Dobrowolska G, Jensen AM, Campbell JS, Fischer EH, Krebs EG . 1994 J. Biol. Chem. 269: 25699–25709
Tolwinski NS, Shapiro PS, Goueli S, Ahn NG . 1999 J. Biol. Chem. 274: 6168–6174
Yung Y, Dolginov Y, Yao Z, Rubinfeld H, Michael D, Hanoch T, Roubini E, Lando Z, Zharhary D, Seger R . 1997 FEBS Lett. 408: 292–296
Yung Y, Yao Z, Aebersold DM, Hanoch T, Seger R . 2001 J. Biol. Chem. 276: 35280–35289
Yung Y, Yao Z, Hanoch T, Seger R . 2000 J. Biol. Chem. 275: 15799–15808
Zheng CF, Guan KL . 1993 J. Biol. Chem. 268: 23933–23939
Acknowledgements
We would like to thank Mrs Tami Hanoch for her technical help. This work was supported by grants from the Benozyio Institute for Molecular Medicine at the Weizmann Institute of Science, the Moross Institute for Cancer Research at the Weizmann Institute of Science, the Estate of Siegmund Landau, and the Israel Academy of Sciences and Humanities.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yao, Z., Flash, I., Raviv, Z. et al. Non-regulated and stimulated mechanisms cooperate in the nuclear accumulation of MEK1. Oncogene 20, 7588–7596 (2001). https://doi.org/10.1038/sj.onc.1204963
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204963
Keywords
This article is cited by
-
LIMK1 nuclear translocation promotes hepatocellular carcinoma progression by increasing p-ERK nuclear shuttling and by activating c-Myc signalling upon EGF stimulation
Oncogene (2021)
-
HAS2-AS1 is a novel LH/hCG target gene regulating HAS2 expression and enhancing cumulus cells migration
Journal of Ovarian Research (2019)
-
MEK nuclear localization promotes YAP stability via sequestering β-TrCP in KRAS mutant cancer cells
Cell Death & Differentiation (2019)
-
Intrinsically active MEK variants are differentially regulated by proteinases and phosphatases
Scientific Reports (2018)
-
Insulin-like growth factor 1 attenuates antiestrogen- and antiprogestin-induced apoptosis in ER+ breast cancer cells by MEK1 regulation of the BH3-only pro-apoptotic protein Bim
Breast Cancer Research (2012)